We keep people on the annual IGRA testing if started on that.  We have been doing this since June 2012 and the previous employees on-boarded with two-step PPD and those stay on annual PPD although we have some who ask to change and we allow that but in general don’t let people switch back and forth between tests because they often do not agree.

 

T. Warner Hudson, MD FACOEM, FAAFP

Medical Director, Occupational and Employee Health

UCLA Health System and Campus

Office 310.825.9146

Fax 310.206.4585

Pager 800.233.7231  ID 27132

E-mail twhudson@mednet.ucla.edu

Website www.ohs.uclahealth.org

 

From: MCOH-EH [mailto:mcoh-eh-bounces+twhudson=mednet.ucla.edu@mylist.net] On Behalf Of Sajjad_Savul@bayhealth.org
Sent: Monday, August 24, 2015 1:50 PM
To: MCOH/EH
Cc: MCOH-EH
Subject: Re: [MCOH-EH] Pre-placement IGRA testing

 

For hospitals using IGRA (Quantiferon TB Gold test/ T-SPOT test) for pre-employment TB screening, what method do you use for periodic (annual) TB screening? Do you continue to use IGRA or revert to PPD.
Thanks.


Sajjad A. Savul, MD, MS, FACOEM
Medical Director
Bayhealth Occupational Health

Dover Office:
1275 S State Street
Dover, DE 19901
Ph.: (302) 678-1303
Milford Office:
301 Jefferson Avenue
Milford, DE 19963
Ph.: (302) 430-5705



CONFIDENTIALITY NOTICE: The information contained in this e-mail message and any attachment(s) is intended only for
the confidential use of the intended recipient(s) named above. This e-mail message and any attachment(s) may contain
confidential health information or other confidential information that is legally privileged and exempt from disclosure under
applicable law. If the reader of this e-mail message is not the intended recipient or the employee agent responsible for
delivering it to the intended recipient, you should be aware that any dissemination, distribution, copying or action taken in
reliance on the content of this e-mail message or any attachment(s) is strictly prohibited. If this e-mail has been received in error, please notify our Risk Management Department at 302-744-7431 and delete or otherwise destroy the original message, any attachment(s) and copies. Thank you for your cooperation.



IMPORTANT WARNING: This email (and any attachments) is only intended for the use of the person or entity to which it is addressed, and may contain information that is privileged and confidential. You, the recipient, are obligated to maintain it in a safe, secure and confidential manner. Unauthorized redisclosure or failure to maintain confidentiality may subject you to federal and state penalties. If you are not the intended recipient, please immediately notify us by return email, and delete this message from your computer.